Biotechnology Bulletin ›› 2016, Vol. 32 ›› Issue (4): 222-227.doi: 10.13560/j.cnki.biotech.bull.1985.2016.04.030

Previous Articles     Next Articles

Intracellular Inhibitory Effect of Synthetic Peptide on Mycobacterium tuberculosis

CHEN Ji ,YIN Yu-he, LI Ling-ling ,JIN Hao, TONG Ming-yi, WU Cong-mei   

  1. School of Chemistry and Life Sciences,Changchun University of Technology,Changchun 130012
  • Received:2015-07-06 Online:2016-04-25 Published:2016-04-26

Abstract: This work is to evaluate the toxicity of the synthetic peptides on mononuclear macrophage THP-1 of human leukemia and the intracellular bacteriostatic effect on Mycobacterium tuberculosis H37Rv. The minimum inhibition concentration(MIC)of the synthetic polypeptide on H37Rv was determined through the different drug concentrations of poly-peptides. Then,the toxic effects of peptide-2 on THP-1 cells were detected using flow cytometry method and MTT method. The colony-forming unit(CFU)method was used for detecting intracellular bacteriostatic effect of peptide-2 on H37Rv. Results were as below:All 4 screened peptides had bacteriostatic effect,the MIC of peptide-2 was 200 mg/mL. When the peptides-2 interacted with THP-1 cells,the cytotoxicity emerged at the concentration of 1200 mg/mL,meaning that there was no significant difference from INH’s cytotoxicity. For intracellular H37Rv,the anti-tuberculosis effects of peptide-2 presented time- and dose- dependent effect,the H37Rv colony count was obviously decreased with the increase of the time and dose. In conclusion,not only has the peptide-2 small toxicity to the macrophage THP-1,but also solid intracellular anti-M. tuberculosis effect,and it can be a new and potential anti-tuberculosis drug.

Key words: synthetic peptide, Mycobacterium tuberculosis, macrophage, intracellular inhibitory